Sotagliflozin, a dual SGLT1/2 inhibitor, increased hemoglobin levels in patients with type 2 diabetes and chronic kidney ...

Patients with symptomatic anemia associated with chronic kidney disease who are on chronic maintenance dialysis can now also ...

Kidney disease results from kidney damage and subsequent decline in kidney function, says Dr. Pooja Budhiraja, a nephrologist ...

Patients with symptomatic anemia associated with chronic kidney disease who are on chronic maintenance dialysis can now also receive vadadustat instead of an erythropoiesis-stimulating agent such ...

Zinc-to-Copper Ratio: Maintaining a balanced zinc-to-copper ratio is crucial, as excessive zinc intake can lead to copper ...

A new study published in the journal of BMC Nephrology showed that the effectiveness of roxadustat is comparable at varying ...

Purpose The evidence evaluating the efficacy of i.v. versus oral iron for the treatment of iron deficiency in non-hemodialysis-dependent patients with chronic kidney disease (CKD) is reviewed.

The 2023 AABB guidelines overall favor a restrictive transfusion strategy, recommending RBC transfusion for hemoglobin <7 ...

The following is a summary of “Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in ...

Patients with symptomatic anaemia associated with chronic kidney disease who are on chronic maintenance dialysis can now also receive vadadustat ...

Without proper treatment, chronic kidney disease can lead to bone disease, anemia, stroke, or heart attack. People with CKD are often placed on a renal (kidney) diet to slow the progression of the ...

When you have chronic kidney disease (CKD), your kidneys slowly stop working properly. The damage is lasting and can get worse over time, leading to different stages of CKD. Anyone can get CKD ...